Events

---

     AE : Adverse Events
     CE : Clinical Events
     DS : Disposition
     DV : Protocol Deviations
     HO : Healthcare Encounters
     MH : Medical History

Findings

---

     CV : Cardiovascular System Findings
     DA : Drug Accountability
     DD : Death Details
     EG : ECG Test Results
     FA : Findings About Events or Interventions
     FT : Functional Tests
     IE : Inclusion/Exclusion Criteria Not Met
     IS : Immunogenicity Specimen Assessments
     LB : Laboratory Test Results
     MB : Microbiology Specimen
     MI : Microscopic Findings
     MK : Musculoskeletal System Findings
     MO : Morphology
     MS : Microbiology Susceptibility
     NV : Nervous System Findings
     OE : Ophthalmic Examinations
     PC : Pharmacokinetics Concentrations
     PE : Physical Examination
     PP : Pharmacokinetics Parameters
     QS : Questionnaires
     RE : Respiratory System Findings
     RP : Reproductive System Findings
     RS : Disease Response and Clin Classification
     SC : Subject Characteristics
     SR : Skin Response
     SS : Subject Status
     TR : Tumor/Lesion Results
     TU : Tumor/Lesion Identification
     UR : Urinary System Findings
     VS : Vital Signs

Interventions

---

     AG : Procedure Agents
     CM : Concomitant/Prior Medications
     EC : Exposure as Collected
     EX : Exposure
     ML : Meal Data
     PR : Procedures
     SU : Substance Use

Relationships

---

     RELREC : Related Records
     RELSUB : Related Subjects
     SUPP-- : Supplemental Qualifiers for [domain name]

Special Purpose

---

     CO : Comments
     DM : Demographics
     SE : Subject Elements
     SM : Subject Disease Milestones
     SV : Subject Visits

Study Reference

---

     OI : Non-host Organism Identifiers

Trial Design

---

     TA : Trial Arms
     TD : Trial Disease Assessments
     TE : Trial Elements
     TI : Trial Inclusion/Exclusion Criteria
     TM : Trial Disease Milestones
     TS : Trial Summary Information
     TV : Trial Visits